Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Introducing EXP Nano Fittings for UHPLC
Monday, April 23, 2012
Optimize Technologies announced the expansion of the EXP Fitting System to include EXP Nano Fittings.

SAW Instruments Launches sam®X Biosensor Access Program
Wednesday, April 11, 2012
Lease the high-end sam®X for six months with no capital spend.

IBN's 'Fish and Chips' May Help Accelerate Drug Discovery
Monday, April 09, 2012
IBN scientists develop cheaper, faster and more efficient platform for preclinical drug discovery applications.

BioDrop Low Volume Cuvette Launched – An Innovative Solution for Accurate Low Volume Spectroscopy from just 1 µl
Monday, March 26, 2012
This microvolume cuvette provides a robust, accurate and affordable approach to low volume spectroscopy.

Microfluidic Expert Dolomite Launches Novel Surface Coating Agent for Improved Droplet Microfluidics
Monday, March 26, 2012
8µl water drop on glass slide (picture on the left) and the same water drop on a Pico-Glide™ treated glass slide.

Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
Friday, March 23, 2012
Dynaflow Resolve chip offers reusability and improved cost-efficiency.

Hamilton Neuros™ Syringe for Neuroscience Research
Thursday, March 22, 2012
Maximizes precision and minimizes injection site damage.

Brazil Scientific Police Advance Drug Testing Facilities
Monday, March 12, 2012
Randox Toxicology Evidence machine adopted by Brazi Police Force.

Connecting the World of Microfluidics
Friday, March 02, 2012
Dolomite’s Multiflux® connectors and interfaces prove extremely popular.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 1049
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed